Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Allen

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Plos One|December 9, 2014
Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastasesSerge Evrard, Graeme Poston, Peter Kissmeyer-Nielsen, et al.
Anticancer Research|July 31, 2013
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survivalCelina Su-Ping Ang, Mark Yipin Sun, David Fidel Huitzil-Melendez, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Multiplexed Glycan Immunofluorescence Identification of Pancreatic Cancer Cell Subpopulations in Both Tumor and Blood SamplesBraelyn Binkowski, Zachary Klamer, ChongFeng Gao, et al.
Science Advances|March 7, 2025
Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samplesBraelyn Binkowski, Zachary Klamer, ChongFeng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2020
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRAChongFeng Gao, Luke Wisniewski, Ying Liu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 9, 2022
Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research NetworkMichael Cavnar, Tara Ghalambor, Michael E Lidsky, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
The Lancet. Oncology|May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisMustafa Suker, Berend R Beumer, Eran Sadot, et al.
Gastroenterology|June 9, 2019
Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic LesionsKoushik K Das, Xin Geng, Jeffrey W Brown, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Plos One|December 9, 2014
Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastasesSerge Evrard, Graeme Poston, Peter Kissmeyer-Nielsen, et al.
Anticancer Research|July 31, 2013
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survivalCelina Su-Ping Ang, Mark Yipin Sun, David Fidel Huitzil-Melendez, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Multiplexed Glycan Immunofluorescence Identification of Pancreatic Cancer Cell Subpopulations in Both Tumor and Blood SamplesBraelyn Binkowski, Zachary Klamer, ChongFeng Gao, et al.
Science Advances|March 7, 2025
Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samplesBraelyn Binkowski, Zachary Klamer, ChongFeng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2020
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRAChongFeng Gao, Luke Wisniewski, Ying Liu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 9, 2022
Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research NetworkMichael Cavnar, Tara Ghalambor, Michael E Lidsky, et al.
Plos One|October 3, 2015
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma SpecimensBrian B Haab, Ying Huang, Seetharaman Balasenthil, et al.
The Lancet. Oncology|May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisMustafa Suker, Berend R Beumer, Eran Sadot, et al.
Gastroenterology|June 9, 2019
Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic LesionsKoushik K Das, Xin Geng, Jeffrey W Brown, et al.
Pageof 11